10-Q 1 hurn-20240930.htm 10-Q hurn-20240930
000128984812/312024Q3false31xbrli:sharesiso4217:USDiso4217:USDxbrli:shareshurn:Segmentxbrli:pureutr:Rateiso4217:INR00012898482024-01-012024-09-3000012898482024-10-2200012898482024-09-3000012898482023-12-3100012898482024-07-012024-09-3000012898482023-07-012023-09-3000012898482023-01-012023-09-300001289848us-gaap:CommonStockMember2024-06-300001289848us-gaap:TreasuryStockCommonMember2024-06-300001289848us-gaap:AdditionalPaidInCapitalMember2024-06-300001289848us-gaap:RetainedEarningsMember2024-06-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000012898482024-06-300001289848us-gaap:CommonStockMember2024-07-012024-09-300001289848us-gaap:TreasuryStockCommonMember2024-07-012024-09-300001289848us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001289848us-gaap:CommonStockMember2024-09-300001289848us-gaap:TreasuryStockCommonMember2024-09-300001289848us-gaap:AdditionalPaidInCapitalMember2024-09-300001289848us-gaap:RetainedEarningsMember2024-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001289848us-gaap:CommonStockMember2023-06-300001289848us-gaap:TreasuryStockCommonMember2023-06-300001289848us-gaap:AdditionalPaidInCapitalMember2023-06-300001289848us-gaap:RetainedEarningsMember2023-06-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-3000012898482023-06-300001289848us-gaap:CommonStockMember2023-07-012023-09-300001289848us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001289848us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001289848us-gaap:CommonStockMember2023-09-300001289848us-gaap:TreasuryStockCommonMember2023-09-300001289848us-gaap:AdditionalPaidInCapitalMember2023-09-300001289848us-gaap:RetainedEarningsMember2023-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000012898482023-09-300001289848us-gaap:CommonStockMember2023-12-310001289848us-gaap:TreasuryStockCommonMember2023-12-310001289848us-gaap:AdditionalPaidInCapitalMember2023-12-310001289848us-gaap:RetainedEarningsMember2023-12-310001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001289848us-gaap:CommonStockMember2024-01-012024-09-300001289848us-gaap:TreasuryStockCommonMember2024-01-012024-09-300001289848us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001289848us-gaap:CommonStockMember2022-12-310001289848us-gaap:TreasuryStockCommonMember2022-12-310001289848us-gaap:AdditionalPaidInCapitalMember2022-12-310001289848us-gaap:RetainedEarningsMember2022-12-310001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-3100012898482022-12-310001289848us-gaap:CommonStockMember2023-01-012023-09-300001289848us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001289848us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001289848hurn:HealthcareSegmentMember2023-12-310001289848hurn:EducationMember2023-12-310001289848hurn:CommercialMember2023-12-310001289848hurn:HealthcareSegmentMember2024-01-012024-09-300001289848hurn:EducationMember2024-01-012024-09-300001289848hurn:CommercialMember2024-01-012024-09-300001289848hurn:HealthcareSegmentMember2024-09-300001289848hurn:EducationMember2024-09-300001289848hurn:CommercialMember2024-09-300001289848us-gaap:CustomerRelationshipsMembersrt:MinimumMember2024-09-300001289848us-gaap:CustomerRelationshipsMembersrt:MaximumMember2024-09-300001289848us-gaap:CustomerRelationshipsMember2024-09-300001289848us-gaap:CustomerRelationshipsMember2023-12-310001289848us-gaap:TechnologyBasedIntangibleAssetsMembersrt:MinimumMember2024-09-300001289848us-gaap:TechnologyBasedIntangibleAssetsMembersrt:MaximumMember2024-09-300001289848us-gaap:TechnologyBasedIntangibleAssetsMember2024-09-300001289848us-gaap:TechnologyBasedIntangibleAssetsMember2023-12-310001289848us-gaap:TradeNamesMember2024-09-300001289848us-gaap:TradeNamesMember2023-12-310001289848us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2024-09-300001289848us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2024-09-300001289848us-gaap:NoncompeteAgreementsMember2024-09-300001289848us-gaap:NoncompeteAgreementsMember2023-12-310001289848us-gaap:CustomerContractsMembersrt:MinimumMember2024-09-300001289848us-gaap:CustomerContractsMembersrt:MaximumMember2024-09-300001289848us-gaap:CustomerContractsMember2024-09-300001289848us-gaap:CustomerContractsMember2023-12-310001289848hurn:ChangeinEstimatedVariableConsiderationMember2024-07-012024-09-300001289848hurn:ReleaseofAllowanceMember2024-07-012024-09-300001289848hurn:ChangeinEstimatedVariableConsiderationMember2023-07-012023-09-300001289848hurn:ReleaseofAllowanceMember2023-07-012023-09-300001289848hurn:ChangeinEstimatedVariableConsiderationMember2024-01-012024-09-300001289848hurn:ReleaseofAllowanceMember2024-01-012024-09-300001289848hurn:ChangeinEstimatedVariableConsiderationMember2023-01-012023-09-300001289848hurn:ReleaseofAllowanceMember2023-01-012023-09-3000012898482024-07-012024-09-3000012898482025-01-012024-09-3000012898482026-01-012024-09-300001289848hurn:ShareRepurchaseProgramMember2020-11-300001289848hurn:ShareRepurchaseProgramMember2024-09-300001289848hurn:ShareRepurchaseProgramMember2024-07-012024-09-300001289848hurn:ShareRepurchaseProgramMember2024-01-012024-09-300001289848hurn:ShareRepurchaseProgramMember2024-01-012024-03-310001289848hurn:ShareRepurchaseProgramMember2023-12-310001289848hurn:ShareRepurchaseProgramMember2023-07-012023-09-300001289848hurn:ShareRepurchaseProgramMember2023-01-012023-09-300001289848hurn:ShareRepurchaseProgramMember2023-01-012023-03-310001289848hurn:ShareRepurchaseProgramMember2022-12-310001289848hurn:RevolverCreditFacilityMember2024-02-010001289848hurn:TermDebtCreditFacilityMember2024-02-010001289848hurn:CreditFacilityMember2024-02-012024-02-290001289848hurn:TermDebtCreditFacilityMember2024-02-012024-02-290001289848hurn:RevolverCreditFacilityMember2024-09-300001289848hurn:TermDebtCreditFacilityMember2024-09-300001289848hurn:CreditFacilityMember2024-02-010001289848srt:MinimumMemberhurn:SecuredOvernightFinancingRateSOFRMemberhurn:RevolverCreditFacilityMember2024-02-012024-02-290001289848srt:MaximumMemberhurn:SecuredOvernightFinancingRateSOFRMemberhurn:RevolverCreditFacilityMember2024-02-012024-02-290001289848srt:MinimumMemberus-gaap:BaseRateMemberhurn:RevolverCreditFacilityMember2024-02-012024-02-290001289848srt:MaximumMemberus-gaap:BaseRateMemberhurn:RevolverCreditFacilityMember2024-02-012024-02-290001289848srt:MinimumMemberhurn:SecuredOvernightFinancingRateSOFRMemberhurn:TermDebtCreditFacilityMember2024-02-012024-02-290001289848srt:MaximumMemberhurn:SecuredOvernightFinancingRateSOFRMemberhurn:TermDebtCreditFacilityMember2024-02-012024-02-290001289848hurn:CreditFacilityMember2024-09-300001289848hurn:RevolverCreditFacilityMember2023-12-310001289848hurn:TermDebtCreditFacilityMember2023-12-310001289848hurn:CreditFacilityMember2023-12-3100012898482024-02-010001289848us-gaap:EmployeeSeveranceMember2024-07-012024-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:NewYorkNYOfficeExitMember2024-07-012024-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMemberhurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember2024-07-012024-09-300001289848us-gaap:EmployeeSeveranceMember2024-01-012024-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMemberhurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember2024-01-012024-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:A200S.MichiganAveOfficeExitMember2024-01-012024-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:NewYorkNYOfficeExitMember2024-01-012024-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:AdditionalImpairmentOnPreviouslyVacatedOfficeSpacesMember2024-01-012024-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:Q32023LexingtonOfficeExitMember2023-07-012023-09-300001289848us-gaap:EmployeeSeveranceMember2023-07-012023-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMemberhurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember2023-07-012023-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:Q32023LexingtonOfficeExitMember2023-01-012023-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:Q12023HillsboroOfficeExitMember2023-01-012023-09-300001289848us-gaap:EmployeeSeveranceMember2023-01-012023-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMemberhurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember2023-01-012023-09-300001289848hurn:AbandonedCapitalizedSoftwareDevelopmentProjectMember2023-01-012023-09-300001289848hurn:OfficeSpaceReductionsMemberhurn:AdditionalImpairmentOnPreviouslyVacatedOfficeSpacesMember2023-01-012023-09-300001289848us-gaap:EmployeeSeveranceMember2023-12-310001289848us-gaap:OtherRestructuringMember2023-12-310001289848us-gaap:OtherRestructuringMember2024-01-012024-09-300001289848us-gaap:EmployeeSeveranceMember2024-09-300001289848us-gaap:OtherRestructuringMember2024-09-300001289848us-gaap:InterestRateSwapMember2024-09-300001289848us-gaap:InterestRateSwapMember2023-12-310001289848us-gaap:InterestRateSwapMember2024-01-012024-09-300001289848us-gaap:ForeignExchangeContractMember2024-01-012024-09-300001289848us-gaap:ForeignExchangeContractMember2024-09-300001289848us-gaap:ForeignExchangeContractMember2023-12-310001289848us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-09-300001289848us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-12-310001289848us-gaap:OtherNoncurrentAssetsMember2024-09-300001289848us-gaap:OtherNoncurrentAssetsMember2023-12-310001289848us-gaap:OtherNoncurrentLiabilitiesMember2024-09-300001289848us-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001289848us-gaap:AccruedLiabilitiesMember2024-09-300001289848us-gaap:AccruedLiabilitiesMember2023-12-310001289848us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2024-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2024-09-300001289848us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848us-gaap:FairValueInputsLevel2Memberhurn:DeferredCompensationPlanAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:DeferredCompensationPlanAssetsMember2024-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300001289848us-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848hurn:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848hurn:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001289848us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2023-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2023-12-310001289848us-gaap:FairValueInputsLevel2Memberhurn:DeferredCompensationPlanAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:DeferredCompensationPlanAssetsMember2023-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001289848us-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848hurn:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848hurn:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001289848hurn:ShorelightHoldingsLlcMemberus-gaap:ConvertibleDebtSecuritiesMember2024-09-300001289848hurn:ShorelightHoldingsLlcMember2024-01-012024-09-300001289848hurn:ShorelightHoldingsLlcMember2023-01-012023-12-310001289848hurn:ShorelightHoldingsLlcMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ConvertibleDebtSecuritiesMember2024-09-300001289848hurn:ShorelightHoldingsLlcMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ConvertibleDebtSecuritiesMember2023-12-310001289848hurn:ShorelightHoldingsLlcMemberus-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ConvertibleDebtSecuritiesMember2024-09-300001289848hurn:ShorelightHoldingsLlcMemberus-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ConvertibleDebtSecuritiesMember2023-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2024-01-012024-09-300001289848hurn:ContingentConsiderationLiabilityMember2024-09-300001289848hurn:ContingentConsiderationLiabilityMember2023-12-310001289848hurn:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-012024-09-300001289848hurn:MedicallyHomeGroupInc.Memberus-gaap:PreferredStockMember2019-12-310001289848hurn:MedicallyHomeGroupInc.Memberus-gaap:PreferredStockMember2024-09-300001289848hurn:MedicallyHomeGroupInc.Memberus-gaap:PreferredStockMember2023-12-310001289848us-gaap:InterestRateSwapMember2024-07-012024-09-300001289848us-gaap:InterestRateSwapMember2023-07-012023-09-300001289848us-gaap:ForeignExchangeContractMember2024-07-012024-09-300001289848us-gaap:ForeignExchangeContractMember2023-07-012023-09-300001289848us-gaap:InterestRateSwapMember2023-01-012023-09-300001289848us-gaap:ForeignExchangeContractMember2023-01-012023-09-300001289848us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001289848us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001289848us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001289848us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-09-300001289848us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001289848us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-3000012898482024-04-012024-06-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2024-07-012024-09-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2023-07-012023-09-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2024-01-012024-09-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2023-01-012023-09-300001289848us-gaap:OperatingSegmentsMemberhurn:EducationMember2024-07-012024-09-300001289848us-gaap:OperatingSegmentsMemberhurn:EducationMember2023-07-012023-09-300001289848us-gaap:OperatingSegmentsMemberhurn:EducationMember2024-01-012024-09-300001289848us-gaap:OperatingSegmentsMemberhurn:EducationMember2023-01-012023-09-300001289848us-gaap:OperatingSegmentsMemberhurn:CommercialMember2024-07-012024-09-300001289848us-gaap:OperatingSegmentsMemberhurn:CommercialMember2023-07-012023-09-300001289848us-gaap:OperatingSegmentsMemberhurn:CommercialMember2024-01-012024-09-300001289848us-gaap:OperatingSegmentsMemberhurn:CommercialMember2023-01-012023-09-300001289848us-gaap:OperatingSegmentsMember2024-07-012024-09-300001289848us-gaap:OperatingSegmentsMember2023-07-012023-09-300001289848us-gaap:OperatingSegmentsMember2024-01-012024-09-300001289848us-gaap:OperatingSegmentsMember2023-01-012023-09-300001289848us-gaap:MaterialReconcilingItemsMember2024-07-012024-09-300001289848us-gaap:MaterialReconcilingItemsMember2023-07-012023-09-300001289848us-gaap:MaterialReconcilingItemsMember2024-01-012024-09-300001289848us-gaap:MaterialReconcilingItemsMember2023-01-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2024-07-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2023-07-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2024-01-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2023-01-012023-09-300001289848hurn:DigitalCapabilityMemberhurn:HealthcareSegmentMember2024-07-012024-09-300001289848hurn:DigitalCapabilityMemberhurn:HealthcareSegmentMember2023-07-012023-09-300001289848hurn:DigitalCapabilityMemberhurn:HealthcareSegmentMember2024-01-012024-09-300001289848hurn:DigitalCapabilityMemberhurn:HealthcareSegmentMember2023-01-012023-09-300001289848hurn:HealthcareSegmentMember2024-07-012024-09-300001289848hurn:HealthcareSegmentMember2023-07-012023-09-300001289848hurn:HealthcareSegmentMember2023-01-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:EducationMember2024-07-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:EducationMember2023-07-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:EducationMember2024-01-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:EducationMember2023-01-012023-09-300001289848hurn:DigitalCapabilityMemberhurn:EducationMember2024-07-012024-09-300001289848hurn:DigitalCapabilityMemberhurn:EducationMember2023-07-012023-09-300001289848hurn:DigitalCapabilityMemberhurn:EducationMember2024-01-012024-09-300001289848hurn:DigitalCapabilityMemberhurn:EducationMember2023-01-012023-09-300001289848hurn:EducationMember2024-07-012024-09-300001289848hurn:EducationMember2023-07-012023-09-300001289848hurn:EducationMember2023-01-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2024-07-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2023-07-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2024-01-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2023-01-012023-09-300001289848hurn:DigitalCapabilityMemberhurn:CommercialMember2024-07-012024-09-300001289848hurn:DigitalCapabilityMemberhurn:CommercialMember2023-07-012023-09-300001289848hurn:DigitalCapabilityMemberhurn:CommercialMember2024-01-012024-09-300001289848hurn:DigitalCapabilityMemberhurn:CommercialMember2023-01-012023-09-300001289848hurn:CommercialMember2024-07-012024-09-300001289848hurn:CommercialMember2023-07-012023-09-300001289848hurn:CommercialMember2023-01-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2024-07-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2023-07-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2024-01-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2023-01-012023-09-300001289848hurn:DigitalCapabilityMember2024-07-012024-09-300001289848hurn:DigitalCapabilityMember2023-07-012023-09-300001289848hurn:DigitalCapabilityMember2024-01-012024-09-300001289848hurn:DigitalCapabilityMember2023-01-012023-09-300001289848hurn:HealthcareSegmentMemberhurn:ConsultingAndManagedServicesCapabilityMember2024-07-012024-09-300001289848hurn:HealthcareSegmentMemberhurn:ConsultingAndManagedServicesCapabilityMember2023-07-012023-09-300001289848hurn:HealthcareSegmentMemberhurn:ConsultingAndManagedServicesCapabilityMember2024-01-012024-09-300001289848hurn:HealthcareSegmentMemberhurn:ConsultingAndManagedServicesCapabilityMember2023-01-012023-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2024-07-012024-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2023-07-012023-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2024-01-012024-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2023-01-012023-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2024-07-012024-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2023-07-012023-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2024-01-012024-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2023-01-012023-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2024-07-012024-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2023-07-012023-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2024-01-012024-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2023-01-012023-09-300001289848hurn:CommercialMemberhurn:ConsultingAndManagedServicesCapabilityMember2024-07-012024-09-300001289848hurn:CommercialMemberhurn:ConsultingAndManagedServicesCapabilityMember2023-07-012023-09-300001289848hurn:CommercialMemberhurn:ConsultingAndManagedServicesCapabilityMember2024-01-012024-09-300001289848hurn:CommercialMemberhurn:ConsultingAndManagedServicesCapabilityMember2023-01-012023-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2024-07-012024-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2023-07-012023-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2024-01-012024-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2023-01-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2024-07-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2023-07-012023-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2024-01-012024-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2023-01-012023-09-300001289848hurn:DigitalCapabilityMember2024-07-012024-09-300001289848hurn:DigitalCapabilityMember2023-07-012023-09-300001289848hurn:DigitalCapabilityMember2024-01-012024-09-300001289848hurn:DigitalCapabilityMember2023-01-012023-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 10-Q 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
OR 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number: 000-50976 
HURON CONSULTING GROUP INC.
(Exact name of registrant as specified in its charter)
 
Delaware 01-0666114
(State or other jurisdiction of
incorporation or organization)
 (IRS Employer
Identification Number)
550 West Van Buren Street
Chicago, Illinois
60607
(Address of principal executive offices)
(Zip Code)
(312) 583-8700
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareHURNNASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated FilerAccelerated Filer
Non-accelerated FilerSmaller Reporting 
Company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of October 22, 2024, 17,740,913 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.


Huron Consulting Group Inc.
HURON CONSULTING GROUP INC.
INDEX



PART I - FINANCIAL INFORMATION
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited) 
September 30,
2024
December 31,
2023
Assets
Current assets:
Cash and cash equivalents$18,497 $12,149 
Receivables from clients, net of allowances of $15,707 and $17,284, respectively
204,894 162,566 
Unbilled services, net of allowances of $3,064 and $5,984, respectively
177,437 190,869 
Income tax receivable9,192 6,385 
Prepaid expenses and other current assets27,789 28,491 
Total current assets437,809 400,460 
Property and equipment, net21,682 23,728 
Deferred income taxes, net2,408 2,288 
Long-term investments64,319 75,414 
Operating lease right-of-use assets21,026 24,131 
Other non-current assets111,448 92,336 
Intangible assets, net22,547 18,074 
Goodwill647,541 625,711 
Total assets$1,328,780 $1,262,142 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$8,151 $10,074 
Accrued expenses and other current liabilities26,490 33,087 
Accrued payroll and related benefits183,182 225,921 
Current maturities of long-term debt13,750  
Current maturities of operating lease liabilities11,990 11,032 
Deferred revenues27,703 22,461 
Total current liabilities271,266 302,575 
Non-current liabilities:
Deferred compensation and other liabilities44,322 35,665 
Long-term debt, net of current portion428,204 324,000 
Operating lease liabilities, net of current portion33,442 38,850 
Deferred income taxes, net28,774 28,160 
Total non-current liabilities534,742 426,675 
Commitments and contingencies
Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 20,793,202 and 21,316,441 shares issued, respectively
207 212 
Treasury stock, at cost, 3,062,689 and 2,852,296 shares, respectively
(159,717)(142,136)
Additional paid-in capital174,872 236,962 
Retained earnings497,664 415,027 
Accumulated other comprehensive income9,746 22,827 
Total stockholders’ equity522,772 532,892 
Total liabilities and stockholders’ equity$1,328,780 $1,262,142 
The accompanying notes are an integral part of the consolidated financial statements.
1

HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)
(In thousands, except per share amounts)
(Unaudited) 
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Revenues:
Revenues before reimbursable expenses$370,049 $358,178 $1,097,664 $1,022,832 
Reimbursable expenses8,040 9,288 24,827 25,918 
Total revenues 378,089 367,466 1,122,491 1,048,750 
Operating expenses:
Direct costs (exclusive of depreciation and amortization included below) 247,849 244,774 749,757 708,355 
Reimbursable expenses8,135 9,497 25,146 26,242 
Selling, general and administrative expenses70,375 64,361 214,485 190,857 
Other gains, net(173)(14)(14,522)(202)
Restructuring charges3,137 5,402 7,530 9,385 
Depreciation and amortization6,321 6,104 18,326 18,621 
Total operating expenses335,644 330,124 1,000,722 953,258 
Operating income 42,445 37,342 121,769 95,492 
Other income (expense), net:
Interest expense, net of interest income(6,800)(5,047)(19,894)(15,146)
Other income (expense), net1,936 (1,000)5,361 1,781 
Total other expense, net(4,864)(6,047)(14,533)(13,365)
Income before taxes37,581 31,295 107,236 82,127 
Income tax expense10,432 9,779 24,599 22,480 
Net income $27,149 $21,516 $82,637 $59,647 
Earnings per share:
Net income per basic share$1.53 $1.15 $4.61 $3.15 
Net income per diluted share$1.47 $1.10 $4.43 $3.05 
Weighted average shares used in calculating earnings per share:
Basic17,754 18,770 17,945 18,941 
Diluted18,471 19,475 18,672 19,578 
Comprehensive income (loss):
Net income $27,149 $21,516 $82,637 $59,647 
Foreign currency translation adjustments, net of tax900 (662)(103)(283)
Unrealized gain (loss) on investment, net of tax(443)(1,350)(8,208)3,076 
Unrealized loss on cash flow hedging instruments, net of tax(4,716)(368)(4,770)(234)
Other comprehensive income (loss)(4,259)(2,380)(13,081)2,559 
Comprehensive income $22,890 $19,136 $69,556 $62,206 
The accompanying notes are an integral part of the consolidated financial statements.
2

HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except share amounts)
(Unaudited)
Three Months Ended September 30,
Common StockTreasury StockAdditional
Paid-In
Capital
Retained
Earnings
Accumulated Other
Comprehensive
Income
Stockholders’
Equity
SharesAmountSharesAmount
Balance at June 30, 202420,834,133 $208 (3,114,873)$(159,537)$175,387 $470,515 $14,005 $500,578 
Comprehensive income (loss)27,149 (4,259)22,890 
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations13,692  2,837 198 (198) 
Exercise of stock options6,987  419 419 
Share-based compensation6,605 6,605 
Shares redeemed for employee tax withholdings(3,814)(378)(378)
Share repurchases(66,354)(1)(7,341)(7,342)
Balance at September 30, 202420,788,458 $207 (3,115,850)$(159,717)$174,872 $497,664 $9,746 $522,772 
Balance at June 30, 202321,732,924 $218 (2,969,196)$(141,407)$279,070 $390,679 $23,058 $551,618 
Comprehensive income (loss)21,516 (2,380)19,136 
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations16,511  385    
Exercise of stock options16,337  1,646 1,646 
Share-based compensation10,063 10,063 
Shares redeemed for employee tax withholdings(3,820)(322)(322)
Share repurchases(290,288)(3)(28,784)(28,787)
Balance at September 30, 202321,475,484 $215 (2,972,631)$(141,729)$261,995 $412,195 $20,678 $553,354 
Nine Months Ended September 30,
Common StockTreasury StockAdditional
Paid-In
Capital
Retained
Earnings
Accumulated Other
Comprehensive
Income
Stockholders’
Equity
SharesAmountSharesAmount
Balance at December 31, 202321,175,554 $212 (2,975,321)$(142,136)$236,962 $415,027 $22,827 $532,892 
Comprehensive income (loss)
82,637 (13,081)69,556 
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations564,130 5 77,657 3,877 (3,882) 
Exercise of stock options29,406  1,634 1,634 
Purchase of business86,913 1 8,639 8,640 
Share-based compensation35,422 35,422 
Shares redeemed for employee tax withholdings(218,186)(21,458)(21,458)
Other capital contributions113 113 
Share repurchases(1,067,545)(11)(104,016)(104,027)
Balance at September 30, 202420,788,458 $207 (3,115,850)$(159,717)$174,872 $497,664 $9,746 $522,772 
Balance at December 31, 202222,231,593 $223 (2,953,147)$(137,556)$318,706 $352,548 $18,119 $552,040 
Comprehensive income59,647 2,559 62,206 
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations322,775 3 122,220 5,877 (5,880) 
Exercise of stock options21,609  987 987 
Purchase of business16,337  1,646 1,646 
Share-based compensation34,958 34,958 
Shares redeemed for employee tax withholdings(141,704)(10,050)(10,050)
Share repurchases(1,116,830)(11)(88,422)(88,433)
Balance at September 30, 202321,475,484 $215 (2,972,631)$(141,729)$261,995 $412,195 $20,678 $553,354 
The accompanying notes are an integral part of the consolidated financial statements.
3

HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine Months Ended
September 30,
20242023
Cash flows from operating activities:
Net income$82,637 $59,647 
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization18,326 18,653 
Non-cash lease expense4,486 4,840 
Lease-related impairment charges3,513 5,584 
Share-based compensation33,963 35,398 
Amortization of debt discount and issuance costs793 577 
Allowances for doubtful accounts3,062 53 
Deferred income taxes5,037 890 
Gain on sale of property and equipment(101)(61)
Change in fair value of contingent consideration liabilities(589)(251)
Changes in operating assets and liabilities, net of acquisitions and divestiture:
(Increase) decrease in receivables from clients, net(44,739)(18,508)
(Increase) decrease in unbilled services, net13,770 (51,092)
(Increase) decrease in current income tax receivable / payable, net(3,114)(4,365)
(Increase) decrease in other assets(8,412)(6,243)
Increase (decrease) in accounts payable and other liabilities(6,994)(5,361)
Increase (decrease) in accrued payroll and related benefits(41,385)10,805 
Increase (decrease) in deferred revenues1,451 4,328 
Net cash provided by operating activities61,704 54,894 
Cash flows from investing activities:
Purchases of property and equipment(6,028)(5,147)
Investments in life insurance policies(2,166)(2,601)
Distributions from life insurance policies 2,956 
Purchases of businesses(20,769)(1,613)
Capitalization of internally developed software costs(19,341)(19,610)
Proceeds from note receivable154 154 
Proceeds from sale of property and equipment102 62 
Net cash used in investing activities(48,048)(25,799)
Cash flows from financing activities:
Proceeds from exercises of stock options1,634 987 
Shares redeemed for employee tax withholdings(21,458)(10,050)
Share repurchases(104,553)(88,897)
Proceeds from bank borrowings682,500 292,000 
Repayments of bank borrowings(563,375)(224,000)
Payments for debt issuance costs(1,446)(58)
Deferred payments on business acquisition(617)(1,500)
Net cash used in financing activities(7,315)(31,518)
Effect of exchange rate changes on cash7 (13)
Net increase (decrease) in cash and cash equivalents6,348 (2,436)
Cash and cash equivalents at beginning of the period12,149 11,834 
Cash and cash equivalents at end of the period$18,497 $9,398 
Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in current liabilities$4,194 $5,308 
Operating lease right-of-use assets obtained in exchange for operating lease liabilities$4,171 $2,320 
Common stock issued related to purchase of business$8,640 $1,646 
Contingent consideration accrued related to purchases of businesses
$36 $374 
Excise tax on net share repurchases included in current liabilities$502 $643 
    The accompanying notes are an integral part of the consolidated financial statements.
4


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

1. Description of Business
Huron is a global professional services firm that collaborates with clients to put possible into practice by creating sound strategies, optimizing operations, accelerating digital transformation, and empowering businesses and their people to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve.
We provide our services and products and manage our business under three operating segments: Healthcare, Education, and Commercial, which align our business by industry. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital, which are methods by which we deliver our services and products.
See Note 14 “Segment Information” for more information on each of our segments and their solutions.
2. Basis of Presentation and Significant Accounting Policies
The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three and nine months ended September 30, 2024 and 2023. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023 and our Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 and June 30, 2024. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
In the second quarter of 2024, we revised the presentation of our consolidated statement of operations and other comprehensive income (loss) to separately present other gains, net previously presented within selling, general and administrative expenses. The change in presentation had no effect on our consolidated results, and our historical consolidated statements of operations and other comprehensive income (loss) were revised for consistent presentation.
In the third quarter of 2024, we revised the line item descriptions of revenues to rename revenues as revenues before reimbursable expenses and to rename total revenues and reimbursable expenses as total revenues. The change in line item description has no impact on the line item totals for any periods presented.
3. New Accounting Pronouncements
Not Yet Adopted
On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which updates the segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. ASU 2023-07 will be effective for our annual reporting periods beginning with the current fiscal year ending December 31, 2024 and for interim reporting periods beginning in fiscal year 2025, with early adoption permitted, and is required to be applied retrospectively. We expect to adopt ASU 2023-07 for our annual reporting period ending December 31, 2024 on a retrospective basis. We expect the adoption will have no impact on our financial position or our results of operations, but will result in additional disclosures.
On December 14, 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which updates annual income tax disclosures by requiring disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2025, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. We expect the adoption will have no impact on our financial position or our results of operations, but will result in additional disclosures.
5


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
On March 6, 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which will require registrants to disclose certain climate-related information in registration statements and annual reports. The disclosure requirements will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2025, subject to any delay which may result from the current administrative stay issued by the SEC. We expect the adoption will have no impact on our financial position or our results of operations, but we are currently evaluating the impact this guidance will have on our disclosures within our consolidated financial statements.
4. Goodwill and Intangible Assets
Goodwill
The table below sets forth the changes in the carrying value of goodwill by reportable segment for the nine months ended September 30, 2024.

Healthcare
EducationCommercialTotal
Balance as of December 31, 2023:
Goodwill$644,983 $123,652 $312,968 $1,081,603 
Accumulated impairment losses(190,024)(1,417)(264,451)(455,892)
Goodwill, net as of December 31, 2023$454,959 $122,235 $48,517 $625,711 
Goodwill recorded in connection with business acquisitions
 21,677 76 21,753 
Foreign currency translation 77  77 
Goodwill, net as of September 30, 2024$454,959 $143,989 $48,593 $647,541 
2024 Acquisitions
On January 1, 2024, we completed the acquisition of the data analytics services team of Vlamis Software Solutions, Inc. (“Vlamis”). The results of operations of Vlamis are included within our consolidated financial statements as of the acquisition date and allocated among our Education and Commercial segments based on the engagements delivered by the business.
On March 1, 2024, we completed the acquisition of Grenzebach Glier and Associates, Inc. (“GG+A”), a philanthropic management consulting firm that helps education institutions and other nonprofit organizations build and accelerate the philanthropic programs that support their mission. The results of operations of GG+A are included within our consolidated financial statements and results of operations of our Education segment as of the acquisition date.
The acquisitions of Vlamis and GG+A are not significant to our consolidated financial statements individually or in the aggregate as of and for the three and nine months ended September 30, 2024. These acquisitions were accounted for using the acquisition method of accounting. Contract assets and contract liabilities are recorded at their carrying value under Topic 606: Revenue from Contracts with Customers. We finalized the measurement of assets acquired, including goodwill, and liabilities assumed in the acquisitions of Vlamis and GG+A in the first and second quarters of 2024, respectively.
6


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Intangible Assets
Intangible assets as of September 30, 2024 and December 31, 2023 consisted of the following:
As of September 30, 2024As of December 31, 2023
Useful Life 
(in years)
Gross
Carrying
Amount
Accumulated
Amortization
Gross
Carrying
Amount
Accumulated
Amortization
Customer relationships
5 to 10
$26,661 $9,022 $60,636 $48,928 
Technology and software
2 to 5
16,230 12,127 16,230 10,195 
Trade names66,000 6,000 6,000 6,000 
Non-competition agreements
3 to 5
950 545 720 389 
Customer contracts
1 to 4
702 302   
Total$50,543 $27,996 $83,586 $65,512 
Identifiable intangible assets with finite lives are amortized over their estimated useful lives using either an accelerated or straight-line basis to correspond to the cash flows expected to be derived from the assets.
Intangible asset amortization expense was $1.6 million and $2.0 million for the three months ended September 30, 2024 and 2023, respectively; and $4.9 million and $6.2 million for the nine months ended September 30, 2024 and 2023, respectively. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of September 30, 2024.
Year Ending December 31,Estimated Amortization Expense
2024$6,518 
2025$6,719 
2026$4,974 
2027$3,582 
2028$2,626 
Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.
5. Revenues
For the three months ended September 30, 2024 and 2023, we recognized total revenues of $378.1 million and $367.5 million, respectively. Of the $378.1 million total revenues recognized in the third quarter of 2024, we recognized $10.9 million from obligations satisfied, or partially satisfied, in prior periods, of which $9.1 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $1.8 million was due to the release of allowances on receivables from clients and unbilled services. Of the $367.5 million total revenues recognized in the third quarter of 2023, we recognized $9.6 million from obligations satisfied, or partially satisfied, in prior periods, of which $7.1 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $2.5 million was due to the release of allowances on receivables from clients and unbilled services.
For the nine months ended September 30, 2024 and 2023, we recognized total revenues of $1.12 billion and $1.05 billion, respectively. Of the $1.12 billion total revenues recognized in the first nine months of 2024, we recognized $22.4 million from obligations satisfied, or partially satisfied, in prior periods, of which $19.1 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $3.3 million was due to the release of allowances on receivables from clients and unbilled services. Of the $1.05 billion total revenues recognized in the first nine months of 2023, we recognized $10.4 million from obligations satisfied, or partially satisfied, in prior periods, of which $9.1 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $1.3 million was due to the release of allowances on receivables from clients and unbilled services.
As of September 30, 2024, we had $186.1 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude variable consideration which has been excluded from the total transaction price due to the constraint and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $186.1 million of performance obligations, we expect to recognize $26.0 million as revenue in 2024, $75.2 million in
7


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
2025, and the remaining $84.9 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.
Contract Assets and Liabilities
The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.
Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset, net balance as of September 30, 2024 and December 31, 2023 was $55.4 million and $70.1 million, respectively. The $14.7 million decrease primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.
Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition accounting policy. Our deferred revenues balance as of September 30, 2024 and December 31, 2023 was $27.7 million and $22.5 million, respectively. The $5.2 million increase reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and nine months ended September 30, 2024, $1.7 million and $21.3 million of revenues recognized were included in the deferred revenue balance as of December 31, 2023, respectively.
6. Earnings Per Share
Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.
Earnings per share under the basic and diluted computations are as follows: 
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2024202320242023
Net income$27,149 $21,516 $82,637 $59,647 
Weighted average common shares outstanding – basic17,754 18,770 17,945 18,941 
Weighted average common stock equivalents717 705 727 637 
Weighted average common shares outstanding – diluted18,471 19,475 18,672 19,578 
Net income per basic share$1.53 $1.15 $4.61 $3.15 
Net income per diluted share$1.47 $1.10 $4.43 $3.05 
The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above for the nine months ended September 30, 2024 and both the three and nine months ended September 30, 2023 was less than 0.1 million shares. There were no anti-dilutive securities for the three months ended September 30, 2024.
In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021.The share repurchase program has been subsequently extended and increased, most recently in the second quarter of 2024. The current authorization extends the share repurchase program through December 31, 2025 with a repurchase amount of $500 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements.
8


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
In the three and nine months ended September 30, 2024, we repurchased and retired 66,354 and 1,067,545 shares for $7.3 million and $104.0 million, respectively, which includes a $0.1 million and $0.5 million accrual for excise taxes on the net share repurchases, respectively. Additionally, in the first quarter of 2024, we settled the repurchase of 10,000 shares for $1.0 million which were accrued as of December 31, 2023.
In the three and nine months ended September 30, 2023, we repurchased and retired 290,288 and 1,116,830 shares for $28.8 million and $88.4 million, respectively, which includes a $0.3 million and $0.6 million accrual for excise taxes on the net share repurchases, respectively. Additionally, in the first quarter of 2023, we settled the repurchase of 15,200 shares for $1.1 million which were accrued as of December 31, 2022.
As of September 30, 2024, $82.7 million remained available for share repurchases under our share repurchase program.
7. Financing Arrangements
The Company has a $600 million senior secured revolving credit facility (the “Revolver”) and a $275 million senior secured term loan facility (the “Term Loan”), subject to the terms of the Third Amended and Restated Credit Agreement dated as of November 15, 2022 (as amended, the “Amended Credit Agreement”), both of which fully mature on November 15, 2027. The Term Loan was established in February 2024 with the execution of Amendment No. 2 to the Third Amended and Restated Credit Agreement. The Term Loan is subject to scheduled quarterly amortization payments of $3.4 million which began June 30, 2024 and continue through the maturity date of November 15, 2027, at which time the outstanding principal balance and all accrued interest will be due.
As of September 30, 2024, we had total borrowings outstanding under our Amended Credit Agreement of $443.1 million, consisting of $175.0 million outstanding under the Revolver and $268.1 million outstanding under the Term Loan. A summary of the scheduled maturities of those borrowings follows:
Scheduled Maturities of Long-Term Debt
2024$3,438 
2025$13,750 
2026$13,750 
2027$412,187 
The initial borrowings under the Revolver were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Revolver may be used for working capital, capital expenditures, share repurchases, permitted acquisitions, and other general corporate purposes. The proceeds of the Term Loan were used to reduce borrowings under the Revolver.
The Amended Credit Agreement provides the option to increase the revolving credit facility or establish additional term loan facilities in an aggregate amount up to $250 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $1.13 billion.
Fees and interest on borrowings under the Amended Credit Agreement vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, these borrowings will bear interest at one, three or six month Term SOFR or, in the case of the Revolver, an alternate base rate, in each case plus the applicable margin. The applicable margin for borrowings under the Revolver will fluctuate between 1.125% per annum and 1.875% per annum, in the case of Term SOFR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time. The applicable margin for the outstanding principal under the Term Loan will range between 1.625% per annum and 2.375% per annum based upon our Consolidated Leverage Ratio at such time. The fees and interest are subject to further adjustment based upon the Company's performance against specified key performance indicators related to certain environmental, social and/or governance goals of the Company. Based upon the performance of the Company against those key performance indicators in each Reference Year (as defined in the Amended Credit Agreement), certain adjustments to the otherwise applicable rates for interest, commitment fees and letter of credit fees will be made. These annual adjustments will not exceed an increase or decrease of 0.01% in the aggregate for all key performance indicators in the case of the commitment fee rate or an increase or decrease of 0.05% in the aggregate for all key performance indicators in the case of the Term SOFR borrowings, base rate borrowings or letter of credit fee rate.
Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in
9


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.
The loans and obligations under the Amended Credit Agreement are secured pursuant to a Third Amended and Restated Security Agreement and a Third Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement) entitled to vote and 100% of the stock or other equity interests in each material first-tier foreign subsidiary not entitled to vote.
The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.25 to 1.00 upon the occurrence of a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At September 30, 2024, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 1.91 to 1.00 and a Consolidated Interest Coverage Ratio of 9.90 to 1.00.
A summary of the carrying amounts of our debt follows:
September 30,
2024
December 31,
2023
Revolver
$175,000 $324,000 
Term Loan
268,125  
Unamortized debt issuance costs - Term Loan1
(1,171) 
Total long-term debt441,954 324,000 
Current maturities of long-term debt
(13,750) 
Long-term debt, net of current portion$428,204 $324,000 
(1)In connection with establishing the Term Loan, we incurred $1.4 million of debt issuance costs which were recognized as a discount to the Term Loan. These debt issuance costs are amortized to interest expense using an effective interest rate of 7.34% over the term of the Term Loan. Unamortized debt issuance costs related to the Revolver are included as a component of other non-current assets and amortized to interest expense using the straight-line method over the term of the Revolver.
Borrowings outstanding under the Amended Credit Agreement as of September 30, 2024 and December 31, 2023 carried a weighted average interest rate of 4.9% and 4.2%, respectively, including the effect of the interest rate swaps described in Note 9 “Derivative Instruments and Hedging Activity.”
The borrowing capacity under the Revolver is reduced by any outstanding borrowings under the Revolver and outstanding letters of credit. At September 30, 2024, we had outstanding letters of credit totaling $0.6 million, which are used as security deposits for our office facilities. As of September 30, 2024, the unused borrowing capacity under the Revolver was $424.4 million.
8. Restructuring Charges
Restructuring charges for the three and nine months ended September 30, 2024 were $3.1 million and $7.5 million, respectively. The $3.1 million restructuring charges recognized in the third quarter of 2024 included $1.3 million of severance-related expenses; a $1.2 million non-cash impairment charge on the right-of-use operating lease asset and fixed assets for a portion of our New York, New York office space that we exited during the third quarter of 2024; and $0.6 million of rent and related expenses, net of sublease income, for previously vacated office spaces. The $7.5 million restructuring charges recognized in the first nine months of 2024 included $2.3 million of severance-related expenses; $1.7 million of rent and related expenses, net of sublease income, for previously vacated office spaces; a $1.4 million non-cash lease impairment charge on the right-of-use operating lease asset and fixed assets of office space previously occupied by GG+A; a
10


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
$1.2 million non-cash impairment charge on the right-of-use operating lease asset and fixed assets for a portion of our office space in New York, New York that we exited during the third quarter of 2024; and $0.8 million related to non-cash lease impairment charges driven by updated sublease assumptions for our previously vacated office spaces.
Restructuring charges for the three and nine months ended September 30, 2023 were $5.4 million and $9.4 million. The $5.4 million of restructuring charges recognized in the third quarter of 2023 included a $3.5 million non-cash impairment charge on the right-of-use operating lease asset and fixed assets for our office space in Lexington, Massachusetts that we exited during the third quarter of 2023; $1.2 million of severance-related expenses; and $0.7 million of rent and related expenses, net of sublease income, for previously vacated office spaces. The $9.4 million of restructuring charges incurred in the first nine months of 2023 included $3.5 million and $1.9 million of non-cash impairment charges on the right-of-use operating lease assets and fixed assets for our office spaces in Lexington, Massachusetts and Hillsboro, Oregon, respectively, which we exited in the first nine months of 2023; $2.2 million of severance-related expenses; $1.3 million of rent and related expenses, net of sublease income, for previously vacated office spaces; $0.3 million related to the abandonment of a capitalized software development project; and $0.2 million related to non-cash lease impairment charges driven by updated sublease assumptions for our previously vacated office spaces.
The table below sets forth the changes in the carrying value of our restructuring charge liability by restructuring type for the nine months ended September 30, 2024.
Employee CostsOther Total
Balance as of December 31, 2023$1,366 $535 $1,901 
Additions2,288  2,288 
Payments(3,445) (3,445)
Adjustments
 13 13 
Balance as of September 30, 2024$209 $548 $757 
All of the $0.2 million restructuring charge liability related to employee costs at September 30, 2024 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits in our consolidated balance sheet. All of the $0.5 million other restructuring charge liability at September 30, 2024, which primarily relates to the early termination of a contract in a prior period, is expected to be paid in the next 12 months and is included as a component of accrued expenses and other current liabilities in our consolidated balance sheet.
9. Derivative Instruments and Hedging Activity
In the normal course of business, we use forward interest rate swaps to manage the interest rate risk associated with our variable-rate borrowings under our senior secured credit facility and we use non-deliverable foreign exchange forward contracts to manage the foreign currency exchange rate risk related to our Indian Rupee-denominated expenses of our operations in India. From time to time, we may enter into additional forward interest rate swaps or non-deliverable foreign exchange forward contracts to further hedge against our interest rate risk and foreign currency exchange rate risk. We do not use derivative instruments for trading or other speculative purposes.
We have designated all of our derivative instruments as cash flow hedges. Therefore, changes in the fair value of the interest rate swaps and foreign exchange forward contracts are recorded to other comprehensive income to the extent effective and reclassified to earnings upon settlement.
Interest Rate Swaps
We are party to forward interest rate swap agreements with aggregate notional amounts of $300.0 million and $250.0 million as of September 30, 2024 and December 31, 2023, respectively. Under the terms of the interest rate swap agreements, we receive from the counterparty interest on the notional amount based on one month Term SOFR and we pay to the counterparty a stated, fixed rate. The forward interest rate swap agreements have staggered maturities through January 31, 2029.
As of September 30, 2024, it was anticipated that $1.8 million of the gains, net of tax, related to interest rate swaps currently recorded in accumulated other comprehensive income will be reclassified into interest expense, net of interest income in our consolidated statement of operations within the next 12 months.
11


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Foreign Exchange Forward Contracts
We are party to non-deliverable foreign exchange forward contracts that are scheduled to mature monthly through August 31, 2025. As of September 30, 2024 and December 31, 2023, the aggregate notional amounts of these contracts were INR 1,390.2 million, or $16.6 million, and INR 1,375.7 million, or $16.6 million, respectively, based on the exchange rates in effect as of each period end.
As of September 30, 2024, it was anticipated that the less than $0.1 million of losses, net of tax, related to foreign exchange forward contracts currently recorded in accumulated other comprehensive income will be reclassified into earnings in our consolidated statement of operations within the next 12 months.
The table below sets forth additional information relating to our derivative instruments as of September 30, 2024 and December 31, 2023.
Derivative InstrumentBalance Sheet LocationSeptember 30,
2024
December 31,
2023
Interest rate swapsPrepaid expenses and other current assets$2,450 $6,655 
Interest rate swapsOther non-current assets204 891 
Foreign exchange forward contractsPrepaid expenses and other current assets5  
Total Assets$2,659 $7,546 
Interest rate swapsDeferred compensation and other liabilities$1,878 $307 
Foreign exchange forward contractsAccrued expenses and other current liabilities67 70 
Total Liabilities$1,945 $377 
All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis in our consolidated balance sheet. Refer to Note 11 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.
10. Fair Value of Financial Instruments
Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:
Level 1 Inputs
Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 InputsQuoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 InputsUnobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.
12


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023.
Level 1Level 2Level 3Total
September 30, 2024
Assets:
Interest rate swaps$— $2,654 $— $2,654 
Convertible debt investment— — 56,951 56,951 
Foreign exchange forward contracts— 5 — 5 
Deferred compensation assets— 41,983 — 41,983 
Total assets$— $44,642 $56,951 $101,593 
Liabilities:
Interest rate swaps$— $1,878 $— $1,878 
Foreign exchange forward contracts— 67 — 67 
Contingent consideration for business acquisitions— — 165 165 
Total liabilities$— $1,945 $165 $2,110 
December 31, 2023
Assets:
Interest rate swaps$— $7,546 $— $7,546 
Convertible debt investment— — 68,046 68,046 
Deferred compensation assets— 34,826 — 34,826 
Total assets$— $42,372 $68,046 $110,418 
Liabilities:
Interest rate swaps$— $307 $— $307 
Foreign exchange forward contracts— 70 — 70 
Contingent consideration for business acquisitions— — 2,074 2,074 
Total liabilities$— $377 $2,074 $2,451 
Interest rate swaps: The fair values of our interest rate swaps were derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and a discount rate reflecting the risks involved. Refer to Note 9 “Derivative Instruments and Hedging Activity” for additional information on our interest rate swaps.
Foreign exchange forward contracts: The fair values of our foreign exchange forward contracts were derived using estimates to settle the foreign exchange forward contracts agreements, which are based on the net present value of expected future cash flows on each contract utilizing market-based inputs, including both forward and spot prices, and a discount rate reflecting the risks involved. Refer to Note 9 “Derivative Instruments and Hedging Activity” for additional information on our foreign exchange forward contracts.
Deferred compensation assets: We have a non-qualified deferred compensation plan (the “Plan”) for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets in our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.
Convertible debt investment: Since 2014, we have invested $40.9 million in the form of 1.69% convertible debt in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. The convertible notes will mature on January 17, 2027, unless converted earlier.
13


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security. We continue to monitor the key factors of our VIE analysis and the terms of the convertible notes to ensure our accounting treatment is appropriate. We have not identified any changes to Shorelight or our investment that would change our classification of the investment as an available-for-sale debt security.
The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. The carrying value is recorded in long-term investments in our consolidated balance sheets. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the probability-weighted assessment of both scenarios. The hybrid analysis utilizes certain assumptions including the assumed holding period through the maturity date of January 17, 2027; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; cash flow projections discounted at the risk-adjusted rate of 23.0% and 24.5% as of September 30, 2024 and December 31, 2023, respectively; and the concluded equity volatility of 40.0% and 35.0% as of September 30, 2024 and December 31, 2023, respectively, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates.
The table below sets forth the changes in the balance of the convertible debt investment for the nine months ended September 30, 2024.
Convertible Debt Investment
Balance as of December 31, 2023$68,046 
Change in fair value(11,095)
Balance as of September 30, 2024$56,951 
Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being measured or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and a discount rate which was 5.9% and 6.3% as of September 30, 2024 and December 31, 2023, respectively. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded to other gains, net in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates.
The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the nine months ended September 30, 2024.
Contingent Consideration for Business Acquisitions
Balance as of December 31, 2023
$2,074 
Acquisition36 
Payment(1,356)
Change in fair value(589)
Balance as of September 30, 2024
$165 
Financial assets and liabilities not recorded at fair value on a recurring basis are as follows:
Preferred Stock Investment
In the fourth quarter of 2019, we invested $5.0 million in a hospital-at-home company. The investment was made in the form of preferred stock. To determine the appropriate accounting treatment for our preferred stock investment, we performed a VIE analysis and concluded that the company does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the preferred
14


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
stock is not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment for our investment to be that of an equity security with no readily determinable fair value. We elected to apply the measurement alternative at the time of the purchase and will continue to do so until the investment does not qualify to be so measured. Under the measurement alternative, the investment is carried at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same company. On a quarterly basis, we review the information available to determine whether an orderly and observable transaction for the same or similar equity instrument occurred or if factors indicate that a significant decrease in value has occurred. We remeasure to the fair value of the preferred stock using such identified information with changes in the fair value recorded to other income (expense), net in our consolidated statement of operations. The carrying value of the preferred stock investment is recorded in long-term investments in our consolidated balance sheets.
During the first nine months of 2024 and 2023, there were no observable price changes or impairments of our preferred stock investment. Since our initial investment, we have recognized cumulative unrealized gains of $28.6 million and cumulative unrealized losses of $26.3 million. As of September 30, 2024 and December 31, 2023, the carrying value of our preferred stock investment was $7.4 million.
Senior Secured Credit Facility
The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 7 “Financing Arrangements” for additional information on our senior secured credit facility.
Cash and Cash Equivalents and Other Financial Instruments
Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.
11. Other Comprehensive Income (Loss)
The table below sets forth the components of other comprehensive income (loss), net of tax, for the three and nine months ended September 30, 2024 and 2023.
Three Months Ended
September 30, 2024
Three Months Ended
September 30, 2023
Before
Taxes
Tax
(Expense)
Benefit
Net of
Taxes
Before
Taxes
Tax
(Expense)
Benefit
Net of
Taxes
Foreign currency translation adjustments$900 $ $900 $(662)$ $(662)
Unrealized gain (loss) on investment$(599)$156 $(443)$(1,840)$490 $(1,350)
Interest rate swaps:
Change in fair value$(3,891)$1,016 $(2,875)$1,849 $(492)$1,357 
Reclassification adjustments into earnings(2,412)630 (1,782)(2,107)560 (1,547)
Net unrealized gain (loss) on interest rate swaps$(6,303)$1,646 $(4,657)$(258)$68 $(190)
Foreign exchange forward contracts:
Change in fair value$(93)$24 $(69)$(223)$59 $(164)
Reclassification adjustments into earnings13 (3)10 (19)5 (14)
Net unrealized gain (loss) on foreign exchange forward contracts$(80)$21 $(59)$(242)$64 $(178)
Other comprehensive income (loss)$(6,082)$1,823 $(4,259)$(3,002)$622 $(2,380)
15


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Nine Months Ended
September 30, 2024
Nine Months Ended
September 30, 2023
Before
Taxes
Tax
(Expense)
Benefit
Net of
Taxes
Before
Taxes
Tax
(Expense)
Benefit
Net of
Taxes
Foreign currency translation adjustments$(103)$ $(103)$(283)$ $(283)
Unrealized gain (loss) on investment$(11,095)$2,887 $(8,208)$4,193 $(1,117)$3,076 
Interest rate swaps:
Change in fair value$578 $(150)$428 $5,307 $(1,411)$3,896 
Reclassification adjustments into earnings(7,041)1,838 (5,203)(5,580)1,483 (4,097)
Net unrealized gain (loss) on interest rate swaps$(6,463)$1,688 $(4,775)$(273)$72 $(201)
Foreign exchange forward contracts:
Change in fair value$(25)$6 $(19)$(23)$6 $(17)
Reclassification adjustments into earnings33 (9)24 (21)5 (16)
Net unrealized gain (loss) on foreign exchange forward contracts$8 $(3)$5 $(44)$11 $(33)
Other comprehensive income (loss)$(17,653)$4,572 $(13,081)$3,593 $(1,034)$2,559 

The before tax amounts reclassified from accumulated other comprehensive income related to our interest rate swaps and foreign exchange forward contracts are recorded to interest expense, net of interest income and direct costs, respectively, on our consolidated statement of operations. The related tax amounts reclassified from accumulated other comprehensive income are recorded to income tax expense (benefit) on our consolidated statement of operations. Refer to Note 9 “Derivative Instruments and Hedging Activity” for additional information on our derivative instruments.

Accumulated other comprehensive income, net of tax, includes the following components: 
Cash Flow Hedges
Foreign Currency TranslationAvailable-for-Sale InvestmentInterest Rate SwapsForeign Exchange Forward ContractsTotal
Balance as of December 31, 2023$(2,521)$20,039 $5,361 $(52)$22,827 
Current period change(103)(8,208)(4,775)5 (13,081)
Balance as of September 30, 2024$(2,624)$11,831 $586 $(47)$9,746 
12. Income Taxes
For the three months ended September 30, 2024, our effective tax rate was 27.8% as we recognized income tax expense of $10.4 million on income of $37.6 million. The effective tax rate of 27.8% was less favorable than the statutory rate, inclusive of state income taxes, of 26.1%, primarily due to certain nondeductible expense items. These unfavorable items were partially offset by a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability.
For the three months ended September 30, 2023, our effective tax rate was 31.2% as we recognized income tax expense of $9.8 million on income of $31.3 million. The effective tax rate of 31.2% was less favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to tax expense related to nondeductible losses on our investments used to fund our deferred compensation liability and certain nondeductible expense items.
For the nine months ended September 30, 2024, our effective tax rate was 22.9% as we recognized income tax expense of $24.6 million on income of $107.2 million. The effective tax rate of 22.9% was more favorable than the statutory rate, inclusive of state income taxes, of 26.1%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2024 and a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability. These favorable items were partially offset by certain nondeductible expense items.
16


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
For the nine months ended September 30, 2023, our effective tax rate was 27.4% as we recognized income tax expense of $22.5 million on income of $82.1 million. The effective tax rate of 27.4% was less favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to certain nondeductible expense items. These unfavorable items were partially offset by a discrete tax benefit for share-based compensation awards that vested during the year.
13. Commitments, Contingencies and Guarantees
Litigation
In the second quarter of 2024, we recognized a pre-tax $15.0 million litigation settlement gain related to a completed legal matter in which Huron was the plaintiff, which is included in other gains, net on our consolidated statement of operations. As of September 30, 2024, all of the $15.0 million settlement was received.
From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.
Guarantees
Guarantees in the form of letters of credit totaling $0.6 million and $0.5 million were outstanding at September 30, 2024 and December 31, 2023, respectively, which are used as security deposits for our office facilities.
In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of September 30, 2024 and December 31, 2023, the total estimated fair value of our outstanding contingent consideration liability was $0.2 million and $2.1 million, respectively.
To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.
14. Segment Information
Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under three operating segments, which are our reportable segments: Healthcare, Education, and Commercial.
Healthcare
Our Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups; payors; and long-term care or post-acute providers. Our healthcare-focused services and products include financial and operational performance improvement consulting, which spans revenue cycle, cost and care delivery transformation; digital offerings, spanning technology and analytic-related services, including enterprise health record (“EHR”), enterprise resource planning (“ERP”) and enterprise performance management (“EPM”), customer relationship management (“CRM”), data management and technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting.
17


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Education
Our Education segment serves public and private colleges and universities, research institutes and other education-related organizations. Our education and research-focused services and products include our digital offerings, spanning technology and analytic-related services, including student information systems, ERP and EPM, CRM, data management and technology managed services and our Huron Research Suite product suite (the leading software suite designed to facilitate and improve research administration service delivery and compliance); our research-focused consulting and managed services; and our strategy and operations consulting services, which span finance, accounting, operations and philanthropy functions, organization and talent strategy, and student and academic strategy.
Commercial
Our Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Our Commercial professionals work primarily with six primary buyers: the chief executive officer, the chief financial officer, the chief strategy officer, the chief human resources officer, the chief operating officer, and organizational advisors, including lenders and law firms. We have a deep focus on serving organizations in the financial services, energy and utilities, industrials and manufacturing industries and the public sector while opportunistically serving commercial industries more broadly, including professional and business services, life sciences, consumer products, and nonprofit. Our Commercial professionals use their deep industry, functional and technical expertise to deliver our digital services and software products, financial advisory (special situation advisory and corporate finance advisory) services, and strategy and innovation consulting services.
Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. We manage our segments on the basis of revenues before reimbursable expenses, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that we bill to our clients at cost. Unallocated corporate expenses include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include corporate office support costs, office facility costs, costs related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management. Our chief operating decision maker does not evaluate segments using asset information.
18


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
The table below sets forth information about our operating segments for the three and nine months ended September 30, 2024 and 2023, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Healthcare:
Revenues before reimbursable expenses$183,136 $179,177 $553,976 $501,994 
Operating income$49,651 $46,888 $147,591 $128,294 
Segment operating income as a percentage of segment revenues before reimbursable expenses27.1 %26.2 %26.6 %25.6 %
Education:
Revenues before reimbursable expenses$121,048 $111,043 $355,384 $325,884 
Operating income$29,158 $26,550 $81,906 $77,112 
Segment operating income as a percentage of segment revenues before reimbursable expenses24.1 %23.9 %23.0 %23.7 %
Commercial:
Revenues before reimbursable expenses$65,865 $67,958 $188,304